Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Update on tissue-engineered biological dressings.

M Ehrenreich1, Z Ruszczak

  • 1Department of Dermatology, New Jersey Medical School, Newark, New Jersey 07079, USA. ehrenrmi@umdj.edu

Tissue Engineering
|September 26, 2006
PubMed
Summary

Tissue-engineered biological dressings show promise for various wounds, including diabetic foot ulcers and burns. Despite commercial challenges, these advanced wound care products are finding specific applications with high clinical utility.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Learning from itch - epidermolysis bullosa is a genetically determined barrier disruption and a chronic inflammatory disease.

Journal of the European Academy of Dermatology and Venereology : JEADV·2021
Same author

Intermittent use of biologic agents for the treatment of psoriasis in adults.

Journal of the European Academy of Dermatology and Venereology : JEADV·2020
Same author

Pyoderma vegetans.

Journal of cutaneous medicine and surgery·2001
Same author

The effect of upper dorsal thoracoscopic sympathectomy on the total amount of body perspiration.

Surgery today·2001
Same author

Modern aspects of wound healing: An update.

Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.]·2000
Same author

Penile Kaposi's sarcoma preceded by chronic penile lymphoedema.

The British journal of dermatology·2000

Area of Science:

  • Regenerative Medicine
  • Biomaterials Science
  • Dermatology

Background:

  • Tissue-engineered biological dressings are developed for treating burns, chronic ulcers, and dermatologic conditions.
  • Prevalence of conditions like diabetic foot ulcers, venous leg ulcers, and pressure ulcers is significant, leading to substantial healthcare burdens.
  • Despite potential, cellular tissue-engineered products face market challenges and unclear mechanisms of action.

Purpose of the Study:

  • To review the current status and applications of tissue-engineered biological dressings.
  • To summarize major indications and available clinical literature for these advanced wound care products.
  • To assess the clinical utility and cost-effectiveness of tissue-engineered dressings.

Main Methods:

Related Experiment Videos

  • Literature review of clinical reports on tissue-engineered biological dressings.
  • Summary of major indications for commercially available products.
  • Analysis of market performance and clinical utility.

    • Main Results:

    • Tissue-engineered dressings are finding niche applications with high clinical utility and defensible costs.
    • Existing products like Dermagraft, Apligraf, and Cultured Epidermal Autograft (Epicel) remain marketed.
    • New products such as OrCel continue to be developed, indicating ongoing innovation.

    Conclusions:

    • Tissue-engineered biological dressings, despite commercial setbacks, are valuable in specific wound care scenarios.
    • Continued development and niche applications suggest a sustained role for these advanced therapies.
    • Further research into mechanisms of action and cost-benefit analysis is warranted.